BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6951506)

  • 1. Langerhans' cells and identification with antibodies.
    Murphy GF; Harrist TJ
    Arch Pathol Lab Med; 1982 May; 106(5):255-6. PubMed ID: 6951506
    [No Abstract]   [Full Text] [Related]  

  • 2. Langerhans' cell and vitiligo: quantitative study of T6 and HLA-DR antigen-expressing cells.
    Claudy AL; Rouchouse B
    Acta Derm Venereol; 1984; 64(4):334-6. PubMed ID: 6209893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OKT6 is not superior to HLA-DR or ATPase as a marker for Langerhans' cells in normal human epidermis.
    Liu HH; Schroeter AL; Muller SA
    Clin Exp Dermatol; 1986 May; 11(3):229-37. PubMed ID: 2943537
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: II. Immunomorphological studies in blood and skin lesions.
    Schmitt D; Thivolet J
    J Clin Immunol; 1982 Jul; 2(3 Suppl):111S-119S. PubMed ID: 6982276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative investigation of Langerhans' cells and potential receptors for HIV in oral, genitourinary and rectal epithelia.
    Hussain LA; Lehner T
    Immunology; 1995 Jul; 85(3):475-84. PubMed ID: 7558138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Langerhans cells: methods of identification].
    Nicolas C; Schmitt D
    Pathol Biol (Paris); 1984 Mar; 32(3):199-208. PubMed ID: 6232489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granuloma annulare. Identification of cells in the cutaneous infiltrate by immunoperoxidase techniques.
    Modlin RL; Vaccaro SA; Gottlieb B; Gebhard JF; Linden CE; Forni M; Meyer PR; Taylor CR; Rea TH
    Arch Pathol Lab Med; 1984 May; 108(5):379-82. PubMed ID: 6370193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Langerhans' cell population studies with OKT6 and HLA-DR monoclonal antibodies in vitiligo patients treated with oral phenylalanine loading and UVA irradiation.
    Westerhof W; Groot I; Krieg SR; Bos JD; Cormane RH
    Acta Derm Venereol; 1986; 66(3):259-62. PubMed ID: 2426905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of primate islets with anti-class II antibodies and complement fails to deplete class II-bearing cells.
    Flynn GJ; Leow CK; Sutton RS; Gray DW; Morris PJ
    Transplant Proc; 1990 Apr; 22(2):786-8. PubMed ID: 2109402
    [No Abstract]   [Full Text] [Related]  

  • 10. [Role of the Langerhans cells in contact allergy].
    Baer RL
    Z Hautkr; 1984 Sep; 59(18):1205-8. PubMed ID: 6437091
    [No Abstract]   [Full Text] [Related]  

  • 11. [The Langerhans cell: a vector of periodontal immunity?].
    Hitzig C; Charbit Y; Monteil RA; Sauget P; Jonesco N; Jasmin JR
    J Parodontol; 1986 Feb; 5(1):35-9. PubMed ID: 3522857
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunological markers of Langerhans' cells in mycosis fungoides skin lesions.
    Tjernlund U
    Acta Derm Venereol; 1982; 62(3):241-3. PubMed ID: 6179366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Regulation of the immune response--findings on the significance of HLA-DR antigens].
    Diezel W; Volc-Platzer B; Volk HD; Stingl G
    Dermatol Monatsschr; 1985; 171(5):303-7. PubMed ID: 3894078
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of Langerhans cells: simultaneous use of sera to intermediate filaments, T6 and HLA-DR antigens on oral mucosa, human epidermis and their tumours.
    Löning T; Caselitz J; Seifert G; Weber K; Osborn M
    Virchows Arch A Pathol Anat Histopathol; 1982; 398(2):119-28. PubMed ID: 6819705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunological mechanisms of contact hypersensitivity].
    Silvennoinen-Kassinen S; Tiilikainen A
    Duodecim; 1985; 101(11):1056-62. PubMed ID: 3874763
    [No Abstract]   [Full Text] [Related]  

  • 16. The DA6-147 monoclonal antibody raised against the HLA-DR alpha chain identifies a cryptic epitope on the BoLA-DR alpha chain.
    Ababou A; Davis WC; Levy D
    Vet Res; 1993; 24(5):402-7. PubMed ID: 7505154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anomolous expression of HLA-DR antigens on human colorectal cancer cells.
    Daar AS; Fuggle SV; Ting A; Fabre JW
    J Immunol; 1982 Aug; 129(2):447-9. PubMed ID: 6953153
    [No Abstract]   [Full Text] [Related]  

  • 18. [Expression of HLA-DR structure and a membrane-specific antigen by a granulocytopoietic line of acute leukemic blast cells].
    Palumbo A; Giovinazzo B; Marmont F; Garbarino G; Paolino F; Pegoraro L
    Boll Soc Ital Biol Sper; 1982 Mar; 58(6):271-4. PubMed ID: 6952888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Langerhans' cells using a monoclonal anti-HLA-DR (Ia-like) antibody.
    Cohen JH; Bouveret E; Pluot M; Revillard JP
    Arch Pathol Lab Med; 1981 Aug; 105(8):438. PubMed ID: 6894853
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro primary sensitization and restimulation of hapten-specific T cells by fresh and cultured human epidermal Langerhans' cells.
    Moulon C; Péguet-Navarro J; Courtellemont P; Redziniak G; Schmitt D
    Immunology; 1993 Nov; 80(3):373-9. PubMed ID: 7507088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.